Executive cognitive performance (healthy adults)
Cognitive optimization in healthy adults — the 'nootropic stack' framing for biohackers, founders, knowledge workers, and students. Distinct from age-related cognitive decline.
What changes during this transition
Several Russian and European-research compounds cluster here under the 'nootropic for healthy adults' framing: semax (registered for stroke recovery — community use for attention/processing speed in healthy users), selank (registered for generalized anxiety — community use for 'calm focus'), bromantane (registered in Russia as Ladasten for asthenia — community use for sustained performance under fatigue), cerebrolysin (multi-peptide porcine brain extract, registered in 50+ countries for stroke / dementia / TBI — community use as IV nootropic), and dihexa (HGF/c-Met mimetic, rodent-only). The honest editorial position is that the source-jurisdiction clinical evidence base is real but lives in CLINICAL populations, not in healthy high-functioning adults; the registered indications don't propagate to wellness-clinic use. Placebo effect in unblinded cognitive self-experimentation is substantial (~30% of any reported effect per Repantis 2010 meta-analysis). The lifestyle baseline — sleep architecture, aerobic exercise, caffeine timing, time-restricted eating — outranks every peptide on this list. Modafinil and methylphenidate are the actual evidentiary gold-standards in healthy-adult cognitive enhancement; nothing in this cluster approaches their effect-size data.
Important caveat
Cognitive optimization in healthy adults is the highest-extrapolation use case in the library — peptides studied in stroke patients, anxiety patients, or transgenic mice are being applied to founders and grad students. Source-jurisdiction registrations (Russia, EU, Mexico) do NOT mean 'safe and effective for healthy adults' — they mean 'approved for a specific clinical population.' If you find yourself relying on a peptide to function day-to-day, the question is sleep, training load, alcohol, undiagnosed ADHD, depression, or thyroid — not whether your stack is dialed in. Bromantane is WADA-prohibited (S6 stimulant class). Dihexa has a documented data-integrity history in its foundational lab work and a mechanistic oncogenic concern (c-Met is a cancer driver). Cerebrolysin is IV/IM only — the administration overhead-to-effect-size ratio is poor for healthy-adult use.
Peptides editorially relevant to executive cognitive performance (healthy adults)
3 peptides from the library — each evidence-tiered honestly.
- SemaxTier 3
Synthetic ACTH(4-10) analog (heptapeptide)
Russian-developed nootropic and neuroprotective peptide. Registered there as a prescription product for stroke; most of the clinical evidence is Russian-language and not independently replicated outside that body of work.
- SelankTier 3
Synthetic tuftsin analog (heptapeptide)
Russian-developed anxiolytic/nootropic peptide. Most clinical data is in Russian and methodologically thin by Western standards. Tier 3. Routes include intranasal — a natural pair with Juno's nasal-spray prep guide.
- BromantaneTier 3
Synthetic adamantane derivative (anti-asthenic / actoprotector)
Russian-developed anti-asthenic. Indirect dopaminergic effect via tyrosine hydroxylase upregulation. Tier 3 in Russian clinical literature; no Western replication. WADA-banned for athletes. Not technically a peptide — included for community completeness.
Want this list to grow? The library is editorial — if there’s a peptide you think belongs on this page with documented or mechanistically-clear evidence, send us a note with the citation and we’ll review it under the same evidence-tier discipline as every other entry.